Muraro 1995.
Methods | Randomized, parallel, single‐blind, controlled study. | |
Participants | N=20; Geographic region: Italy Mean age: 42.5 Discontinuations/Not available to follow‐up: none reported | |
Interventions | Seaprose S (a proteolytic enzyme reported to have anti‐inflammatory action) 30 mg + hyperthermia (combo)(n=10) vs. Hyperthermia (mono) [1 hr session x 7 each; 42.5 ‐ 43.5C] (n=10). Study duration: 2 weeks | |
Outcomes | Symptomatic changes; Instrumental tests (uroflowmetry; transurethral prostatic echography). | |
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment (selection bias) | Unclear risk | B ‐ Unclear |